Investing Profile

Michael Gladstone

VCInvestor

Partner at Atlas Venture

Your Intro Paths to Michael Gladstone

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Michael is a member of

Harvard University Network

252 CONNECTIONS

L.E.K. Consulting Network

11 CONNECTIONS

Find Michael Gladstone on

Current Investing Position

Investment Range

$10.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Michael Gladstone is on these Sector & Stage Rankings

Michael Gladstone's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Diagonal Therapeutics	Series AApr 2024$130M	$130M
Co-investors: Jernej Godec (Atlas Venture), James N. Topper (Frazier Healthcare Partners)
SAPI	UndisclosedMar 2023	$10M
Co-investors: Edward Lando (Pareto Holdings), Jon Oringer (Pareto Holdings), Nadav Ben-Chanoch (Pareto Holdings), Mark Ransford (Double Prime LLP), Will Neale (Passion Capital), Lopo Champalimaud (V3 Ventures), Robert Dighero (Passion Capital), Mik Attisani, Tom Blomfield, Oscar Pierre
Pheon Therapeutics	Series ASep 2022$68M	$68M
Co-investors: Jonathan Tobin (Brandon Capital Partners), Rogier Rooswinkel (Forbion)
Versanis Bio	Series AAug 2021$70M	$70M
Co-investors: Joe Jimenez (Aditum Bio)
Day One Biopharmaceuticals	Series BFeb 2021$130M Series AMay 2020$60M	$190M
Co-investors: Julie Grant (Canaan Partners), Derek DiRocco (RA Capital), Dan Becker (Access Biotechnology)
Third Harmonic Bio	Series AJan 2019$50M	$50M
Co-investors: David Bonita (OrbiMed), Jason Rhodes (Atlas Venture)
Spero Therapeutics	Series BFeb 2016$30M Series AJun 2015$30M Series AApr 2014$3M SeedDec 2013	$120M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Reza Halse (RA Capital), Jean-François Formela (Atlas Venture), Vikas Goyal (SR One)
Surface Oncology	Series AJan 2015$35M	$35M
Co-investors: Elliott Sigal